Cargando…
Health economics: the start of clinical freedom
BACKGROUND: Since Professor Hampton announced the death of clinical freedom in 1983, the increasing influence of Evidence-based Medicine and Health Technology Assessment has contributed to augment the feeling that clinicians have a secondary role in the therapeutic decision-making process. DISCUSSIO...
Autores principales: | , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2902467/ https://www.ncbi.nlm.nih.gov/pubmed/20584277 http://dx.doi.org/10.1186/1472-6963-10-183 |
_version_ | 1782183765974450176 |
---|---|
author | Sacristán, José Antonio Costi, María Valladares, Amparo Dilla, Tatiana |
author_facet | Sacristán, José Antonio Costi, María Valladares, Amparo Dilla, Tatiana |
author_sort | Sacristán, José Antonio |
collection | PubMed |
description | BACKGROUND: Since Professor Hampton announced the death of clinical freedom in 1983, the increasing influence of Evidence-based Medicine and Health Technology Assessment has contributed to augment the feeling that clinicians have a secondary role in the therapeutic decision-making process. DISCUSSION: This article constitutes a reflection on how clinicians may use the results of economic evaluations in their daily clinical practice, making decisions about cost-effectiveness on a case by case basis, and addressing both the patient's and society's needs. To that end, some illustrating examples are taken from the literature to show there are factors with great impact on cost-effectiveness results that can be easily identified and modified by clinicians. SUMMARY: The evolution of the discipline and the trend towards a tailored therapy suggest that health economics is not the end of clinical freedom but the start of it. |
format | Text |
id | pubmed-2902467 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-29024672010-07-13 Health economics: the start of clinical freedom Sacristán, José Antonio Costi, María Valladares, Amparo Dilla, Tatiana BMC Health Serv Res Debate BACKGROUND: Since Professor Hampton announced the death of clinical freedom in 1983, the increasing influence of Evidence-based Medicine and Health Technology Assessment has contributed to augment the feeling that clinicians have a secondary role in the therapeutic decision-making process. DISCUSSION: This article constitutes a reflection on how clinicians may use the results of economic evaluations in their daily clinical practice, making decisions about cost-effectiveness on a case by case basis, and addressing both the patient's and society's needs. To that end, some illustrating examples are taken from the literature to show there are factors with great impact on cost-effectiveness results that can be easily identified and modified by clinicians. SUMMARY: The evolution of the discipline and the trend towards a tailored therapy suggest that health economics is not the end of clinical freedom but the start of it. BioMed Central 2010-06-28 /pmc/articles/PMC2902467/ /pubmed/20584277 http://dx.doi.org/10.1186/1472-6963-10-183 Text en Copyright ©2010 Sacristán et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Debate Sacristán, José Antonio Costi, María Valladares, Amparo Dilla, Tatiana Health economics: the start of clinical freedom |
title | Health economics: the start of clinical freedom |
title_full | Health economics: the start of clinical freedom |
title_fullStr | Health economics: the start of clinical freedom |
title_full_unstemmed | Health economics: the start of clinical freedom |
title_short | Health economics: the start of clinical freedom |
title_sort | health economics: the start of clinical freedom |
topic | Debate |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2902467/ https://www.ncbi.nlm.nih.gov/pubmed/20584277 http://dx.doi.org/10.1186/1472-6963-10-183 |
work_keys_str_mv | AT sacristanjoseantonio healtheconomicsthestartofclinicalfreedom AT costimaria healtheconomicsthestartofclinicalfreedom AT valladaresamparo healtheconomicsthestartofclinicalfreedom AT dillatatiana healtheconomicsthestartofclinicalfreedom |